Australija - engleski - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - glucose, quantity: 33 g/l; sodium chloride, quantity: 3 g/l - injection, solution - excipient ingredients: water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - glucose, quantity: 25 g/l; sodium chloride, quantity: 4.5 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

ani pharmaceuticals, inc. - memantine hydrochloride (unii: jy0wd0ua60) (memantine - unii:w8o17sjf3t) - memantine hydrochloride extended-release capsules are indicated for the treatment of moderate to severe dementia of the alzheimer's type. memantine hydrochloride extended-release capsules are contraindicated in patients with known hypersensitivity to memantine hydrochloride or to any excipients used in the formulation. risk summary there are no adequate data on the developmental risk associated with the use of memantine hydrochloride extended-release capsules in pregnant women. adverse developmental effects (decreased body weight and skeletal ossification) were observed in the offspring of rats administered memantine during pregnancy at doses associated with minimal maternal toxicity. these doses are higher than those used in humans at the maximum recommended daily dose of memantine hydrochloride extended-release capsules [see data]. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. the ba

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

astrazeneca limited - sodium chloride 0.9% - solution for injection - 0.9% w/v - active: sodium chloride 0.9% excipient: hydrochloric acid water for injection

Australija - engleski - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - sodium chloride, quantity: 234 mg/ml - injection, concentrated - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 01 january 1991 : as an additive to parenteral fluids in patients who have specific electrolyte needs for sodium or chloride ions. as a sclerosing agent for small symptomatic varicose veins.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

nephron sc inc. - sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698) - sodium chloride injection, usp is indicated as a source of water and electrolytes. 0.9% sodium chloride injection, usp is also indicated for use as a priming solution in hemodialysis procedures. none known.

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - potassium chloride 0.15%{relative}; sodium chloride 0.9%{relative} - solution for infusion - active: potassium chloride 0.15%{relative} sodium chloride 0.9%{relative} excipient: water for injection - indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - potassium chloride 0.224%; sodium chloride 0.9% - solution for infusion - 30 mmol/l - active: potassium chloride 0.224% sodium chloride 0.9% - indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

multichem nz limited - sodium chloride 9 mg/ml - solution for injection - 0.9% w/v - active: sodium chloride 9 mg/ml excipient: water for injection

Irska - engleski - HPRA (Health Products Regulatory Authority)

maco pharma (uk) ltd - sodium chloride - solution for infusion - 0.9 %w/v - electrolytes